Browse every story filed under this topic, curated from trusted publishers around the world.
Trump’s Plan to Expand Access to Weight-Loss Drugs Just Hit a Major Roadblock
Medicare’s proposed pilot to cover GLP-1 drugs like Wegovy and Zepbound has been delayed.
Read full story →
I’m a dietitian - this is why weight-loss jabs like Mounjaro or Wegovy might not work well for everyone
There are potential genetic influences that can change the way the body responds to weight-loss drugs
CMS pauses weight-loss BALANCE model for Medicare
CMS is holding off on its voluntary “Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth” model pilot for Medicare …
The Oral GLP-1 Tracker: Following the launch trajectories of Lilly’s Foundayo, Novo’s Wegovy pill
Fierce Pharma is launching the weekly Oral GLP-1 Tracker, leveraging analysts’ notes and IQVIA data to monitor prescription trends and …
Why some people are resistant to weight-loss drugs, according to a dietitian
Dietitian warns there are potential genetic influences that can change the way the body responds to weight-loss drugs
Struggling to shift the pounds on weight-loss injections? This could be why
New findings could partially help explain why some people appear to lose weight more quickly than others while taking the …
You've seen all articles for #weight-loss.
Check back
soon
for new stories.